Parisier Titanio
US$ 19500.00
Description
Tratamiento de sangrados en pacientes con deficiencia congénita de factor VII
5 mg es un medicamento antineoplásico que contiene bortezomib
Presentación: Bolsa Contiene: 3 Piezas Etapa: Extra Grande (5) 12 a 16 Kg Género: Unisex
Tratamiento de episodios hemorrágicos en pacientes con hemofilia A
DESOD OBAO RSA TEN 48H R-ON 65G SARACOSMET Tratamiento de sangrados en pacientes
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
